Seres Therapeutics (MCRB) Non-Current Debt (2014 - 2024)
Seres Therapeutics (MCRB) reported Non-Current Debt of $102.49 million for Q2 2024, up 1.7% from $100.74 million a year earlier and up 0.5% from the prior quarter.
Seres Therapeutics (MCRB) Non-Current Debt (2014 - 2024) Analysis & Trends
At the end of FY2023, Seres Therapeutics posted Non-Current Debt of $101.54 million, up 100.7% from FY2022.
- Non-Current Debt has a four-year compound annual growth rate of 42.5% (FY2019 to FY2023).
- By year, Non-Current Debt came in at $50.59 million in FY2022 (+105.3%), $24.64 million in FY2021 (unchanged), $24.64 million in FY2020 (unchanged) and $24.65 million in FY2019.
- The Q2 2024 figure ranks as the highest quarterly Non-Current Debt in data going back to Q4 2014.
- Year over year, Non-Current Debt has now increased in each of the last ten quarters, with growth averaging 90.2% over the last eight quarters.
- The high point for year-over-year Non-Current Debt in five years was Q3 2022 (growth of 215.5%); the low point was Q3 2021 (a decline of 35.5%).
- Per Business Quant data, the three quarters before Q2 2024 came in at $102.01 million (Q1 2024), $101.54 million (Q4 2023) and $101.14 million (Q3 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.08 Bn | 1,101.67 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 616.40 Bn | 534.93 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 501.19 Bn | 474.31 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 367.18 Bn | 321.56 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 261.67 Bn | 235.36 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 235.57 Bn | 190.97 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 190.62 Bn | 164.82 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 169.63 Bn | 116.28 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Seres Therapeutics | 22.76 Mn | -116.07 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 102.49 Mn |
| Mar 31, 2024 | 102.01 Mn |
| Dec 31, 2023 | 101.54 Mn |
| Sep 30, 2023 | 101.14 Mn |
| Jun 30, 2023 | 100.74 Mn |
| Mar 31, 2023 | 51.23 Mn |
| Dec 31, 2022 | 50.59 Mn |
| Sep 30, 2022 | 50.86 Mn |
| Jun 30, 2022 | 50.63 Mn |
| Mar 31, 2022 | 50.44 Mn |
| Dec 31, 2021 | 24.64 Mn |
| Sep 30, 2021 | 16.12 Mn |
| Jun 30, 2021 | 19.04 Mn |
| Mar 31, 2021 | 21.87 Mn |
| Dec 31, 2020 | 24.64 Mn |
| Sep 30, 2020 | 24.98 Mn |
| Jun 30, 2020 | 24.86 Mn |
| Mar 31, 2020 | 24.75 Mn |
| Dec 31, 2019 | 24.65 Mn |
| Jun 30, 2015 | 727,000.00 |
Seres Therapeutics Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=MCRB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();